P-cadherin expression was strongly associated with tumor aggressiveness, being a good indicator of clinical outcome. Moreover, the aberrant expression of P-cadherin in breast cancer might be regulated by gene promoter hypomethylation.
No takes yet. Share an insight, caveat, or question.
Paredes et al. (2005) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: